Abstract:The beta-catenin pathway plays a critical role in the pathogenesis of certain types of cancers. To gain insight into mechanisms by which altered receptor tyrosine kinases regulate cytoplasmic beta-catenin accumulation, the effect of an oncogenic receptor originated from Nantes (RON) variant on beta-catenin accumulation and the role of beta-catenin in RON-mediated tumorigenic activities were studied. In NIH3T3 cells harboring oncogenic variant RON Delta 160, increased beta-catenin accumulation with tyrosine phosphorylation and nuclear translocation was observed. Overexpression of RON Delta 160 also resulted in increased expression of beta-catenin target genes c-myc and cyclin D1. By analyzing cellular proteins that regulate beta-catenin stabilities, it was found that RON Delta 160 activates the protein disheveled (DVL) and inactivates glycogen synthase kinase-3 beta by Ser-9 residue phosphorylation. These effects were channeled by RON Delta 160-activated PI 3-kinase-AKT pathways that are sensitive to specific inhibitors, such as wortmannin, but not to other chemical inhibitors. Silencing RON Delta 160 expression by specific small interfering RNA blocked not only beta-catenin expression but also c-myc and cyclin D1 expression, suggesting that RON expression is required for the activation of the beta-catenin signaling pathway. Moreover, it was found that knockdown of the beta-catenin gene expression by small interfering RNA techniques reduces significantly the RON Delta 160-mediated NIH3T3 cell proliferation, focus-forming activities and anchorage-independent growth. Thus, the oncogenic RON variant regulates beta-catenin stabilities through activation of DVL and inactivation of glycogen synthase kinase-3 beta. The activated beta-catenin cascade is one of the pathways involved in tumorigenic activities mediated by the oncogenic RON variant.

Overexpression Of Calcineurin B Subunit (Cnb) Enhances The Oncogenic Potential Of Hek293 Cells

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

Chp2 Activates the Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway and Enhances the Oncogenic Potential of Hek293 Cells

Transcriptional Upregulation of Calcineurin Aβ by Endothelin-1 is Partially Mediated by Calcium/calmodulin-Dependent Protein Kinase IIδ3 in Rat Cardiomyocytes

The Novel MGC13096 Protein is Correlated with Proliferation.

Expression of Calcineurin Signaling Pathway in Tumorigenesis of Colorectal Carcinoma

CNN3 Acts As a Potential Oncogene in Cervical Cancer by Affecting RPLP1 Mrna Expression

Regulator of calcineurin 1 controls growth plasticity of adult pancreas

[Role of Calcineurin in Cardiac Fibroblast Proliferation Stimulated by Angiotensin II].

Regucalcin is a Novel Target of Beta‐catenin in Liver

Calcineurin B1 subunit in human peripheral blood mononuclear cells and its role in idiopathic membranous nephropathy

Biochemical analyses reveal new insights into RCAN1/Rcn1 inhibition of calcineurin

Calcineurin inactivation inhibits pyruvate dehydrogenase complex activity and induces the Warburg effect

CCN3 increases BMP-4 expression and bone mineralization in osteoblasts

Calcineurin-mediated dephosphorylation enhances the stability and transactivation of c-Myc

[Involvement of Calcineurin-Dependent Signal Pathway in the Angiotensin II-induced Cardiac Myocyte Hypertrophy].

NUCB2 promotes hepatocellular carcinoma cell growth and metastasis by activating the E2F4/PTGR1 axis

Data from Cyclin-Dependent Kinase-3–Mediated C-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation

Role of Calcineurin in Angiotensin II-induced Cardiac Myocyte Hypertrophy of Rats.

Cdk3-Mediated C-Jun Phosphorylation At Ser63 And Ser73 Enhances Cell Transformation

The Role of Calcineurin in the Lung Fibroblasts Proliferation and Collagen Synthesis Induced by Basic Fibroblast Growth Factor.